Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-22T12:40:17.674Z Has data issue: false hasContentIssue false
  • English
  • Français

Tuberculosis drug resistance in England and Wales. How much is ‘home-grown’?

Published online by Cambridge University Press:  02 January 2001

A. C. HAYWARD ,
J. HERBERT  and
J. M. WATSON
A. C. HAYWARD
Affiliation:
Public Health Laboratory Service, Communicable Disease Surveillance Centre, London and Department of Public Health and Epidemiology University of Nottingham, UK
J. HERBERT
Affiliation:
Public Health Laboratory Service, Communicable Disease Surveillance Centre, London, UK
J. M. WATSON
Affiliation:
Public Health Laboratory Service, Communicable Disease Surveillance Centre, London, UK
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The fact that a substantial proportion of tuberculosis drug resistance (especially multidrug resistance) is due to transmission of resistant strains or treatment failure in the UK underlines the need to strengthen control in this country. Early identification and effective treatment of cases (including measures to support adherence and appropriate use of initial treatment regimes involving at least four drugs in those at risk of isoniazid resistance) would help to control the problem [1].

Type
SHORT REPORT
Information
Epidemiology & Infection , Volume 125 , Issue 2 , October 2000 , pp. 463 - 464
Copyright
© 2000 Cambridge University Press